FDA Approves 2 New First-Line Treatments for Breast Cancer

Women with an aggressive form of breast cancer now have two powerful new treatment options that work better than chemotherapy alone.

The drugs represent the first major breakthrough in over 20 years for treating metastatic triple-negative breast cancer.